Savior LLC Vertex Pharmaceuticals Inc Transaction History

Savior LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$177.01 - $223.45 $3,009 - $3,798	-17 Closed	0 $0
Q3 2021 Oct 05, 2021	SELL	$181.39 - $202.99 $18,139 - $20,299	-100 Reduced 85.47%	17 $3,000
Q1 2021 Apr 27, 2021	SELL	$207.02 - $241.31 $3,933 - $4,584	-19 Reduced 13.97%	117 $25,000
Q2 2020 Jul 28, 2020	BUY	$225.48 - $295.8 $3,833 - $5,028	17 Added 14.29%	136 $39,000
Q1 2020 Apr 22, 2020	SELL	$199.77 - $247.81 $998 - $1,239	-5 Reduced 4.03%	119 $28,000
Q4 2019 Jan 22, 2020	BUY	$166.71 - $223.91 $20,672 - $27,764	124 New	124 $27,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Savior LLC, based on Form 13F filings with the SEC.

Stay updated on Savior LLC with notifications on news.